Shapira J - Search Results

1

Soluble C-erbb-2 (p185) in breast-cancer patients in relation to prognosis.

Klein B, Levin I, Kfir B, Marinski R, Rakowski E, Shapira J, Weil R, Mishaeli M, Klein T. Klein B, et al. Among authors: shapira j. Oncol Rep. 1995 Sep;2(5):759-61. doi: 10.3892/or.2.5.759. Oncol Rep. 1995. PMID: 21597811

2

The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.

Klein B, Levin I, Kfir B, Mishaeli M, Shapira J, Klein T. Klein B, et al. Among authors: shapira j. Tumour Biol. 1995;16(5):290-6. Tumour Biol. 1995. PMID: 7652467

3

Elevated pretreatment levels of soluble CD8 and Beta-2-microglobulin as indicators of relapse in breast-cancer patients.

Klein B, Levin I, Lurie H, Nyska A, Shapira J, Kravits M, Klein T. Klein B, et al. Among authors: shapira j. Int J Oncol. 1994 Feb;4(2):471-4. doi: 10.3892/ijo.4.2.471. Int J Oncol. 1994. PMID: 21566948

4

Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burden.

Klein B, Klein T, Figer A, Bleiberg M, Shapira J, Loven D, Livni E, Lurie H, Niska A. Klein B, et al. Among authors: shapira j. Cancer. 1991 May 1;67(9):2295-9. doi: 10.1002/1097-0142(19910501)67:9<2295::aid-cncr2820670915>3.0.co;2-t. Cancer. 1991. PMID: 2013037

5

The expression of HLA class I antigen in prostate cancer in relation to tumor differentiation and patient survival.

Levin I, Klein T, Kuperman O, Segal S, Shapira J, Gal R, Hart Y, Klein B. Levin I, et al. Among authors: shapira j. Cancer Detect Prev. 1994;18(6):443-5. Cancer Detect Prev. 1994. PMID: 7867017

6

Expression of HLA class I and class II in gastric carcinoma in relation to pathologic stage.

Klein B, Klein T, Nyska A, Shapira J, Figer A, Schwartz A, Rakovsky E, Livni E, Lurie H. Klein B, et al. Among authors: shapira j. Tumour Biol. 1991;12(2):68-74. doi: 10.1159/000217690. Tumour Biol. 1991. PMID: 2028181

7

Ovarian volume in postmenopausal breast cancer patients treated with tamoxifen.

Cohen I, Altaras MM, Beyth Y, Zalel Y, Shapira J, Yigael D, Tepper R. Cohen I, et al. Among authors: shapira j. Gynecol Oncol. 1997 Jan;64(1):105-8. doi: 10.1006/gyno.1996.4512. Gynecol Oncol. 1997. PMID: 8995556 Clinical Trial.

8

Endometrial cancers in postmenopausal breast cancer patients with tamoxifen treatment.

Cohen I, Azaria R, Fishman A, Tepper R, Shapira J, Beyth Y. Cohen I, et al. Among authors: shapira j. Int J Gynecol Pathol. 1999 Oct;18(4):304-9. doi: 10.1097/00004347-199910000-00003. Int J Gynecol Pathol. 1999. PMID: 10542937

9

The value of sonohysterography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.

Markovitch O, Tepper R, Aviram R, Fishman A, Shapira J, Cohen I. Markovitch O, et al. Among authors: shapira j. Gynecol Oncol. 2004 Sep;94(3):754-9. doi: 10.1016/j.ygyno.2004.06.033. Gynecol Oncol. 2004. PMID: 15350369

10

Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen.

Cohen I, Beyth Y, Tepper R, Shapira J, Zalel Y, Figer A, Cordoba M, Yigael D, Altaras MM. Cohen I, et al. Among authors: shapira j. Gynecol Oncol. 1996 Jan;60(1):54-8. doi: 10.1006/gyno.1996.0011. Gynecol Oncol. 1996. PMID: 8557228 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters